Ticker Symbol: NPCE
NeuroPace Inc
$12.45 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001528287
Company Profile
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy, and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: www.neuropace.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $8.41
Change:
-$0.64
(
-7.07%)
Days Range: $8.36 - $9.31
Beta: 1.25
52wk. High: $9.73
52wk. Low: $1.22
Ytd. Change 500.31%
50 Day Moving Average: $7.80
200 Day Moving Average: $5.39
Shares Outstanding: 25859643
Valuation
Market Cap: 21.7B
PE Ratio: -
EPS (TTM): -1.69
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A